Status:
RECRUITING
Non-invasive Brain Tumor Molecular Diagnostics and Monitoring
Lead Sponsor:
The Institute of Molecular and Translational Medicine, Czech Republic
Conditions:
Brain Tumor
Eligibility:
All Genders
18-99 years
Brief Summary
This prospective multicenter study aims to enroll GBM patients who will undergo repeated assessments (preoperatively and 3 months post-surgery) to detect circulating tumor cells and analyze the transc...
Eligibility Criteria
Inclusion
- Adult patients with brain tumors -
Exclusion
- No other cancer; no inflammatory disease
- \-
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06501521
Start Date
January 1 2020
End Date
December 31 2030
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurosurgery, University Hospital Olomouc
Olomouc, Czechia, 77900